semaglutide cardiovascular news today SELECT: Semaglutide's Impact on CVD Events Emerges Quickly A new analysis of the

Weight-loss drug approved to treat sleep apnea in Canada Sleep apnea causes daytime sleepiness and is often tied to obesity Health Canada has approved weight-loss drug Zepbound for treating obstructive sleep apnea in adults with obesity

Ozempic may cause diabetic retinopathy Semaglutide, the active ingredient in Ozempic, may increase the risk of early worsening of diabetic retinopathy (damage to the retina of the eye), particularly in people who already have this eye condition

In addition, there is evidence from preclinical studies that ES (POS in particular) affects mitochondria in the brain

Often, PAPs provide financial assistance or drug-free products, usually through in-kind product donations to low-income individuals to reduce existing prescription drug expenses

M.ArodaV

doi: 10.1007/s00018-011-0633-6 214 BhushanBApteU